Respiratory outcomes at 6 months follow up after SARS-Cov-2 infection in people with cystic fibrosis
P. Medino (Milano, Italy), C. Rosazza (Milano, Italy), M. Boraso (Verona, Italy), F. Ciciriello (Roma, Italy), M. Cipolli (Verona, Italy), A. Gramegna (Milano, Italy), V. Lucidi (Roma, Italy), A. Biffi (Milano, Italy), E. Nazzari (Milano, Italy), G. Alicandro (Milano, Italy), C. Colombo (Milano, Italy)
Source: International Congress 2022 – Cystic fibrosis in children and adolescents
Session: Cystic fibrosis in children and adolescents
Session type: Thematic Poster
Number: 283
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Medino (Milano, Italy), C. Rosazza (Milano, Italy), M. Boraso (Verona, Italy), F. Ciciriello (Roma, Italy), M. Cipolli (Verona, Italy), A. Gramegna (Milano, Italy), V. Lucidi (Roma, Italy), A. Biffi (Milano, Italy), E. Nazzari (Milano, Italy), G. Alicandro (Milano, Italy), C. Colombo (Milano, Italy). Respiratory outcomes at 6 months follow up after SARS-Cov-2 infection in people with cystic fibrosis. 283
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|